EU Indices slightly down this morning TA focus on Vivendi
European stocks report 20 April 2020: Polymetal | EssilorLuxottica | Vivendi | Philips...
Share this:
INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Related tags:
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
USD/JPY Q4 2026 Outlook: Hawkish Fed Pricing Clashes With Intervention Risk
The year-end tug-of-war is clear: hawkish Fed pricing supports USD/JPY, while intervention risk limits the upside.
Japanese Yen Forecast: USD/JPY 4% Rally Challenges Post-Intervention Downtrend 9 24 2026
USD/JPY momentum has shifted sharply higher, putting a major resistance confluence in focus as U.S. and Japanese event risk builds.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.